e present invention relates to aryl triazole derivs. of Formula I having antitumoral activity through, as one possible biol. target, the mol. chaperone heat shock protein 90 (Hsp90) inhibition. The invention includes the use of such compds. in medicine, in relation to cancer disease as well as other diseases where an inhibition of Hsp90 is responsive, and the pharmaceutical compn. contg. such compds

Giannini, G., Cabri, W., Vesci, L., Cervoni, M.L., Pisano, C., Taddei, M., et al. (2012)Aryl triazole compounds with antitumoural activity. . Brevetto No. WO 2012084602 A1.

Aryl triazole compounds with antitumoural activity

TADDEI, MAURIZIO;FERRINI, SERENA
2012-01-01

Abstract

e present invention relates to aryl triazole derivs. of Formula I having antitumoral activity through, as one possible biol. target, the mol. chaperone heat shock protein 90 (Hsp90) inhibition. The invention includes the use of such compds. in medicine, in relation to cancer disease as well as other diseases where an inhibition of Hsp90 is responsive, and the pharmaceutical compn. contg. such compds
2012
Giannini, G., Cabri, W., Vesci, L., Cervoni, M.L., Pisano, C., Taddei, M., et al. (2012)Aryl triazole compounds with antitumoural activity. . Brevetto No. WO 2012084602 A1.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/35114
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo